Search

everythinglearnresearchcommunity

for

Search:↓

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

Progesterone reduces anxiety and depression in female mice by increasing BDNF in the brain, needing 5α-reduction and estradiol.

GnRH agonist effectively diagnoses and treats postmenopausal hyperandrogenism from ovarian sources.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

Progesterone and allopregnanolone increase glycine release in rat brain cells.

A substance called prostaglandin D2 is linked to stopping hair growth in men with common baldness.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

BroadAMP-GPT effectively creates antimicrobial peptides to fight drug-resistant bacteria.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Inhibiting PDE8A may help treat hair loss by boosting fat cell growth and hair regeneration.

Progesterone reduces anxiety without needing progesterone receptors.

Ticagrelor works better than clopidogrel in reducing platelet activity in elderly patients with acute coronary syndrome.

Progesterone reduces spinal reflex activity by increasing certain GABA(A) receptor subtypes.

Prasugrel is better than clopidogrel at preventing heart damage and improving blood flow in small heart vessels during heart artery procedures.

Rimegepant causes more nausea and skin issues, while ubrogepant causes more muscle issues; personalized treatment is important.

Compound 6 is a promising candidate for better wound healing.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Adding a small amount of TPGS to minoxidil can help hair growth, but too much TPGS reduces this effect and increases minoxidil in the blood.

Gambogic Amide may prevent hair greying and promote hair growth by maintaining hair pigmentation.

A specific gene mutation is linked to a hereditary form of dystonia that responds well to certain medications.

Adjusting estradiol-ANGPT2 levels can promote hair growth in female pattern hair loss.

Different types of PPARγ are found in varying amounts in human skin and its parts, which could affect how skin treatments work.

Progesterone and its metabolites can prevent seizures without major side effects.

Dutasteride potentially improves cell survival and reduces retinal damage in retinitis pigmentosa.

GLP-1 receptor agonists may increase the risk of a specific type of hair loss called androgenetic alopecia.

Allopregnanolone may enhance alcohol's effects on dopamine neurons, influencing addiction risk.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Prostaglandin F2α analogs show promise for treating certain types of hair loss but need more research for other skin conditions.